Theremia

👥 17 employees💰 Last funded Aug 2024
Biotechnology Research
LinkedIn
Theremia is a pioneering health tech company focused on transforming drug development through advanced AI technologies. We specialize in optimizing drug derivatives for specific population subgroups, with a focus on neurological disorders. Our platform aims to improve treatment efficacy and reduce side effects, ultimately providing more personalized and effective healthcare solutions. At Theremia, we work at the intersection of AI, data science, and pharma to create groundbreaking innovations in medicine. Our mission is to help pharmaceutical companies unlock the full potential of their treatments by identifying and targeting diverse patient needs. Interested in collaborating or testing our pilot program? Contact us at: contact@theremia.health
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
2
Frequently asked questions
Who invested in Theremia?
Theremia has 2 investors on record on gritt.io.
When did Theremia last raise funding?
The most recent investment in Theremia recorded on gritt.io was in August 2024.
What industry is Theremia in?
Theremia operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.